Development of New Drugs: Research, Launch and Access

holders of a first-cycle degree from domestic or equivalent university departments, recognized by NARIC, foreign institutions, as well as graduates of other departments of domestic or equivalent technological educational institutions, recognized abroad, such as health professionals (doctors, pharmacists, biologists, nurses, health economists and administrative executives of nursing units) who work in the broader field of medicine and want to learn the basic principles of development, research, approval, circulation and placement of medicines in the pharmaceutical market, patient access to them, but also to delve into the practical application of reimbursement, evaluation and pricing procedures, etc. Indicatively, participants may be physicians with an interest in administration, executives of public organizations in the health sector (Hospitals, Ministry of Health, EOPYY, EOF, etc.), researchers with expertise in drug and health services research, and executives of private companies active in health (private hospitals, pharmaceutical companies, biomedical technology companies, companies conducting clinical trials, etc.).

Education on the international and local procedures of research, approval, launch and reimbursement of a new drug.